Mckesson Medical-Surgical Inc. Corporate Office recalls Nitrostat (Nitroglycerin Sublingual Tablets, USP) 0.4 mg/tablet, 25-count bottle, Rx only, Distributed by: Pfizer Parke-
Recalled June 15, 2022 · FDA recall D-1049-2022 · Mckesson Medical-Surgical Inc. Corporate Office
Hazard
cGMP deviations: Temperature abuse · FDA Class II
Units
1 carton/4 bottles per carton/25 tablets per bottle
Sold at
USA nationwide.
Description
cGMP deviations: Temperature abuse
Product
Nitrostat (Nitroglycerin Sublingual Tablets, USP) 0.4 mg/tablet, 25-count bottle, Rx only, Distributed by: Pfizer Parke-Davis, Division of Pfizer Inc., NDC 0071-0418-13
Manufacturer(s)
Mckesson Medical-Surgical Inc. Corporate Office
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →